A researcher has developed a simple, cheap and highly accurate device for diagnosing a frequently fatal lung disease which attacks immune deficient individuals such as cancer patients and bone marrow transplant recipients.
US News & World Report released the 25th edition of the annual Best Hospitals rankings. For the first time, the Mayo Clinic in Rochester, Minn, claimed the number 1 spot.
Experts from the world’s leading lung organizations, including the ATS, ERS and ACCP, are calling on governments to ban or restrict the use of e-cigarettes until their health impacts are better known.
Drive Medical has acquired healthcare product manufacturer Medquip Inc, according to a July 2nd company announcement. Financial terms of the deal were not disclosed.
A White House department reportedly edited language in the FDA’s proposed rules for tobacco products that may weaken and limit the agency’s ability to regulate e-cigarettes and cigars, according to published documents cited by a Reuters news article.
The American College of Chest Physicians (CHEST) has published new guidelines for the management of pulmonary arterial hypertension (PAH). including 79 recommendations and expert consensus statements to aid clinicians in the management of PAH using the latest drug therapies for adults with the condition.
Hill-Rom Holdings Inc has signed a definitive agreement to purchase TRUMPF Medical for approximately $250 million in cash, according to a company news announcement.
Nicotine excessively mutates a cell’s DNA, according to researchers at the Virginia Bioinformatics Institute who have labeled the chemical a “formidable carcinogen” and say that nicotine-infused smoking cessation products, like e-cigarettes, may not be the safest way to help smokers quit.
Take our Sleep Center Survey and help us report on industry trends such as salary, reimbursement, home testing, and how these and other developments are projected to impact your sleep lab and patient base.
Medtronic Inc has entered into a definitive agreement to acquire Covidien plc in a cash-and-stock transaction valued at $93.22 per Covidien share, or a total of approximately $42.9 billion, according to a joint press release.